Myeloid sarcoma: current approach and therapeutic options
- PMID: 23556098
- PMCID: PMC3573418
- DOI: 10.1177/2040620711410774
Myeloid sarcoma: current approach and therapeutic options
Abstract
Myeloid sarcoma is a rare disease that can present as an isolated extramedullary leukemic tumor, concurrently with or at relapse of acute myeloid leukemia. Owing to the rarity of this disorder, most of the literature comprises small retrospective studies and case reports. The aim of this review is to summarize the current published data regarding the clinical presentation, morphological, cytogenetic and molecular features, prognosis and treatment of myeloid sarcoma.
Keywords: acute myeloid leukemia; myeloid sarcoma; prognosis; therapy.
Conflict of interest statement
The authors declare no conflicts of interest in preparing this article.
References
-
- Abe R., Umezu H., Uchida T., Kariyone S., Maseki N., Kaneko Y., et al. (1986) Myeloblastoma with a 8;21 chromosome translocation in acute myeloblastic leukemia. Cancer 58: 1260–1264 - PubMed
-
- Ansari-Lari M.A., Yang C.-F., Tinawi-Aljundi R., Cooper L., Long P., Allan R.H., et al. (2004) FLT3 mutations in myeloid sarcoma. Br J Haematol 126: 785–791 - PubMed
-
- Avni B.R., Rund D., Levin M., Grisaro S., Ben-Yehuda D., Paltiel O. (2011) Clinical implicationsof acute myeloid leukemia presenting as granulocyticsarcoma. Hematol Oncol, in press.
-
- Bekassy A.N., Hermans J., Gorin N.C., Gratwohl A. (1996) Granulocytic sarcoma after allogeneic bone marrow transplantation: A retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 17: 801–808 - PubMed
-
- Bloomfield C.D., Lawrence D., Byrd J.C., Carroll A., Pettenati M.J., Tantravahi R., et al. (1998) Frequency of prolonged remission duration after highdose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 58: 4173–4179 - PubMed
LinkOut - more resources
Full Text Sources
